The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 415.00
Bid: 410.00
Ask: 420.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.439%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 415.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Metalcraft secures Phase 2 Sellafield box contract

1 Jun 2021 07:00

RNS Number : 2823A
Avingtrans PLC
01 June 2021
 

1st June 2021

 

Avingtrans plc

("Avingtrans" or the "Company")

 

Metalcraft secures next phase of the Sellafield Limited box contract

 

Stainless Metalcraft (Metalcraft), part of Avingtrans PLC's Process Solutions and Rotating Equipment division and Sellafield Limited, have mutually agreed to exercise the option, to enter into the second phase of the contract to provide high integrity stainless steel storage boxes for Sellafield. The 3M3 ('three metre cubed') box contract (the "contract") is now worth up to £70m and represents an approximately £20m uplift to the original contract awarded in 2015. The agreement to exercise the option marks Metalcraft's successful transition to the second phase of the 3M3 box work with Sellafield.

 

The boxes will be used to store intermediate level waste ("ILW") retrieved from silos at legacy locations in Cumbria. In environmental terms, this storage project represents one of the most positive and important intergenerational equity deliverables of the next few decades, developing and implementing critical technology to bequeath a pristine environment to posterity.

 

As part of this transition, Metalcraft will be producing circa 1,000 boxes over phase two of the programme, which is currently expected to take 6 years, with revenue being recognized evenly across this period.

 

Metalcraft has invested since 2015, in creating the only dedicated facility to supply boxes for ILW in the UK. As a result, the Board believes it is in a leading position to tender for future contracts at Sellafield over the duration the site decommissioning.

 

The Contract underpins the Group's outlook for FY22 and beyond and the Board is pleased to see Metalcraft's pipeline significantly expanding, as it establishes itself as a trusted supplier to Sellafield and commences a number of new tender processes for a wider array of projects in the nuclear decommissioning sector.

 

Austen Adams, managing director of Avingtrans' Process Solutions and Rotating Equipment division, said: "Moving on to phase two of the contract is a tremendous achievement for Metalcraft and is just reward for the hard work and expertise the team has put into developing the 3M3 programme over the last five years.

 

"Having proven the technology and manufacturing processes involved, we are now in a position to ramp up production further and begin the transition towards large scale volume production, which will enable us to support Sellafield in this essential decommissioning work over the coming years.

 

Metalcraft and Avingtrans are proud to be working alongside a number of suppliers and the Nuclear Decommissioning Authority ("NDA") on the project of decommissioning the Sellafield nuclear site, in a way which is both safe and environmentally friendly.

 

Susan Lussem, Supply Chain Director, Sellafield Ltd, said: "Retrieval of wastes from Sellafield's legacy ponds and silos is nationally important work, and we're dedicated to ensuring this is done as safely, quickly and cost-effectively as possible." 

 

"Moving the waste into modern storage will mean a huge reduction in the UK's nuclear hazard, but before we can remove the waste, we have to be confident we have somewhere safe to put it and that we have a reliable supply of containers for decades to come." 

 

"The development, innovation and investment that Sellafield Ltd and Metalcraft have delivered on this project to date gives us this confidence."

 

Steve McQuillan, CEO of Avingtrans, said: "Winning the initial contract back in 2015 was a landmark moment for Metalcraft, allowing us to invest significantly in both infrastructure and personnel, to create a world-class centre for the manufacture of ILW containers, and boosting our apprenticeship programme. This training programme can now be securely extended for the long term, providing skilled engineering apprentice roles in a relatively deprived area of the UK."

 

"Securing the next phase of works wholly justifies that investment and vindicates the Board's decision to refocus what was previously our Energy and Medical Division on new markets. Sellafield's trust in Metalcraft to deliver this next phase of the project endorses the quality of our management processes in this highly sensitive technology."

 

About the NDA & Sellafield:

 

The Nuclear Decommissioning Authority (NDA) is a non-departmental public body created through the Energy Act 2004. In 2016 NDA took direct ownership of Sellafield Ltd, which now operates as a wholly owned subsidiary of NDA, thus replacing the PBO model which had operated at Sellafield for 6 years.

 

It employs just over 300 staff and has offices in Cumbria, Caithness, Cheshire, London and Oxfordshire. It owns 17 sites across England, Wales and Scotland, some dating back to the 1940s, plus the associated liabilities and assets. For further information, please click here.

 

ENDS

 

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

 

N+1 Singer (Nominated Adviser)

02074 963000

Shaun Dobson/Alex Bond (Corporate Finance)

Rachel Hayes (Corporate Broking)

 

 

Newgate (Financial PR)

02076 539850

Adam Lloyd/ Tom Carnegie

 

 

Notes to editor:

About Avingtrans plc:

Avingtrans  designs,  manufactures  and supplies  original  equipment,  systems  and  associated aftermarket services to the energy, medical and industrial markets worldwide.

 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

 

Energy Steel, Inc - Lapeer, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub- assemblies and systems.

 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast

&explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

 

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has remained at the forefront of MRI systems technology, successfully designing and commercialising a 1.5 Tesla extremity MRI superconducting magnet that is now the heart of over two hundred MRI systems world-wide. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFIFLAEEIAFIL
Date   Source Headline
26th Mar 202411:15 amRNSPDMR Dealings
21st Mar 20245:15 pmRNSExercise of Options, PDMR Dealings & TVR
20th Mar 20243:39 pmRNSHolding(s) in Company
4th Mar 20246:10 pmRNSPDMR Dealings
28th Feb 20247:00 amRNSInterim Results
18th Jan 20247:00 amRNSTrading Update and Notice of Results
15th Dec 20233:00 pmRNSExercise of Options & TVR
4th Dec 20237:00 amRNSMagnetica Limited appoints US distributor
22nd Nov 20237:00 amRNSEmployee & PDMR Share Incentive Awards
16th Nov 20232:20 pmRNSResult of AGM
13th Nov 20237:00 amRNSHayward Tyler Contract Win
11th Oct 20237:00 amRNSContract Wins
28th Sep 20235:54 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNSPreliminary results for the year ended 31 May 2023
25th Sep 20237:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSCompletion of Acquisition of Adaptix Ltd
4th Sep 20237:00 amRNSBoard Update
7th Aug 20237:00 amRNSAcquisition of Slack & Parr and Adaptix update
13th Jul 20237:00 amRNSTrading Update & Possible Acquisition of Adaptix
5th Jun 20237:00 amRNSBoard Changes
22nd Feb 20237:00 amRNSInterim Results
15th Feb 20237:00 amRNSAdaptix appoints Willem Baralt as new Chairman
30th Jan 20237:00 amRNSAdaptix secures 510(k) clearance from FDA
27th Jan 20231:19 pmRNSEmployee & PDMR Share Incentive Awards
23rd Jan 20236:12 pmRNSPDMR Dealings
18th Jan 20237:00 amRNSAdditional Investment in Magnetica
16th Jan 20237:00 amRNSTrading Update, Acquisitions and Notice of Results
23rd Dec 20228:30 amRNSExercise of Options, PDMR Dealings & TVR
14th Dec 20227:00 amRNSSteve McQuillan appointed as Chairman of Adaptix
17th Nov 20223:56 pmRNSResult of Annual General Meeting
28th Sep 20227:00 amRNSPreliminary results for the year ended 31 May 2022
27th Jul 20222:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update and Notice of Results
11th Apr 20227:00 amRNSHayward Tyler Secures Nuclear Contracts worth $7m
6th Apr 202212:59 pmRNSExercise of Options and Total Voting Rights
29th Mar 20225:13 pmRNSPDMR Dealing
21st Mar 20227:00 amRNSEnergy Steel Secures Nuclear Contract worth $4.1m
17th Mar 20227:00 amRNSContract Wins
23rd Feb 20227:00 amRNSDirectorate Change
23rd Feb 20227:00 amRNSInterim Results
20th Jan 20227:00 amRNSTrading Update, Notice of Results and Investment
29th Nov 20215:57 pmRNSEmployee & PDMR Share Incentive Awards
22nd Nov 20212:32 pmRNSExercise of Options, PDMR Dealings and TVR
18th Nov 202112:41 pmRNSResult of AGM
13th Oct 20217:00 amRNSInvestment in emerging medtech leader, Adaptix
29th Sep 20217:00 amRNSPreliminary Results for the year ended 31 May 2021
12th Aug 202112:20 pmRNSExercise of Options and Total Voting Rights
12th Jul 202110:51 amRNSExercise of Options, PDMR Dealings and TVR
12th Jul 20217:00 amRNSAvingtrans’ businesses nuclear contract
8th Jul 20217:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.